52 related articles for article (PubMed ID: 17931705)
1. Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.
Klemann CJHM; Xicoy H; Poelmans G; Bloem BR; Martens GJM; Visser JE
Mol Neurobiol; 2018 Jul; 55(7):5639-5657. PubMed ID: 29019056
[TBL] [Abstract][Full Text] [Related]
2. Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO.
Zhelev Z; Bakalova R; Aoki I; Lazarova D; Saga T
ACS Chem Neurosci; 2013 Nov; 4(11):1439-45. PubMed ID: 24024751
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.
Zeng XS; Geng WS; Jia JJ
ASN Neuro; 2018; 10():1759091418777438. PubMed ID: 29809058
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease, lights and melanocytes: looking beyond the retina.
Willis GL; Moore C; Armstrong SM
Sci Rep; 2014 Jan; 4():3921. PubMed ID: 24473093
[TBL] [Abstract][Full Text] [Related]
5. Toxin-Induced Experimental Models of Learning and Memory Impairment.
More SV; Kumar H; Cho DY; Yun YS; Choi DK
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598124
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant-Rich Fraction of Urtica dioica Mediated Rescue of Striatal Mito-Oxidative Damage in MPTP-Induced Behavioral, Cellular, and Neurochemical Alterations in Rats.
Bisht R; Joshi BC; Kalia AN; Prakash A
Mol Neurobiol; 2017 Sep; 54(7):5632-5645. PubMed ID: 27624385
[TBL] [Abstract][Full Text] [Related]
8. Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin.
Moreira CG; Barbiero JK; Ariza D; Dombrowski PA; Sabioni P; Bortolanza M; Da Cunha C; Vital MA; Lima MM
Neurotox Res; 2012 Apr; 21(3):291-301. PubMed ID: 21953489
[TBL] [Abstract][Full Text] [Related]
9. Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease.
Ariza D; Lima MM; Moreira CG; Dombrowski PA; Avila TV; Allemand A; Mendes DA; Da Cunha C; Vital MA
Neurochem Res; 2010 Oct; 35(10):1620-7. PubMed ID: 20582568
[TBL] [Abstract][Full Text] [Related]
10. The MPTP model of Parkinson's disease.
Smeyne RJ; Jackson-Lewis V
Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
[TBL] [Abstract][Full Text] [Related]
11. [Experimental models, of Parkinson disease].
Luquin MR
Rev Neurol; 2000 Jul 1-15; 31(1):60-6. PubMed ID: 10948587
[TBL] [Abstract][Full Text] [Related]
12. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
[TBL] [Abstract][Full Text] [Related]
13. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
14. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
15. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
